How to Get Testosterone Enanthate in Michigan

Who Can Prescribe Testosterone Enanthate in Michigan

Any Michigan-licensed prescriber with an active DEA registration may write a prescription for testosterone enanthate. That includes physicians (MD and DO), nurse practitioners, and physician assistants. Michigan's Public Health Code (MCL 333.17211) grants NPs full practice authority after 2,000 hours of supervised practice under a collaborative agreement, after which they can prescribe Schedule III controlled substances independently. PAs in Michigan must maintain a collaborative practice agreement with a supervising physician to prescribe controlled substances under MCL 333.17048.

The Endocrine Society's 2018 clinical practice guideline recommends that clinicians confirm hypogonadism with at least two morning serum total testosterone levels below 300 ng/dL before initiating therapy. A single low reading is not sufficient. The guideline also advises against prescribing testosterone to men who are actively trying to conceive, given the suppressive effect on spermatogenesis.

Telehealth platforms operating in Michigan must comply with the Michigan Public Health Code and hold appropriate state medical licenses. Many national TRT telehealth services now hold Michigan licenses and can prescribe testosterone enanthate after a video consultation, lab review, and confirmed diagnosis.

Lab Requirements Before Starting Testosterone Enanthate

You will not receive a legitimate prescription without bloodwork. The minimum panel includes two morning total testosterone draws (collected between 7:00 and 10:00 AM, when testosterone peaks in the diurnal cycle), a complete blood count (CBC), a comprehensive metabolic panel (CMP), and a lipid panel. Men aged 40 and older should also have a prostate-specific antigen (PSA) test.

The American Urological Association (AUA) guidelines define testosterone deficiency as a total testosterone below 300 ng/dL measured on at least two occasions. Free testosterone or bioavailable testosterone may be checked if total testosterone falls in the 250 to 400 ng/dL range and clinical suspicion remains high, particularly in obese patients whose sex hormone-binding globulin (SHBG) levels may artificially lower total T readings.

Additional labs your clinician may order based on clinical context:

• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH): to distinguish primary from secondary hypogonadism
• Prolactin: to rule out prolactinoma if LH/FSH are suppressed
• Estradiol: baseline measurement before initiating therapy
• Hemoglobin A1c: the T-Trials (N=790) demonstrated that testosterone therapy improved several markers in men with type 2 diabetes and low testosterone, reinforcing the connection between metabolic health and androgen status
• DEXA scan: if osteoporosis risk factors are present

Most telehealth TRT providers in Michigan will either send you a lab order for a local Quest Diagnostics or Labcorp draw, or accept recent labs (typically within 6 months) that include the required panels.

Telehealth Access for Testosterone Enanthate in Michigan

Michigan permits synchronous telehealth prescribing of controlled substances. After the federal COVID-era flexibilities were codified, the DEA's 2025 telemedicine rule allows initial Schedule III prescriptions via video evaluation without requiring a prior in-person visit, provided the prescriber holds a valid DEA registration and state license.

The practical steps for a Michigan resident using telehealth:

1. Sign up with a telehealth TRT provider licensed in Michigan
2. Complete bloodwork at a local lab (ordered by the provider or self-pay through a third-party lab service)
3. Attend a video consultation where the clinician reviews your labs, symptoms, and medical history
4. Receive a prescription sent electronically to your chosen pharmacy
5. Pick up or receive delivery of testosterone enanthate

Turnaround from initial sign-up to first injection typically runs 7 to 14 days. That timeline depends on lab scheduling, result turnaround (usually 2 to 4 business days), and pharmacy availability. Some telehealth providers partner with 503A compounding pharmacies that ship directly, which can shave a day or two off the process.

The TRAVERSE trial (N=5,246), the largest randomized testosterone trial to date, found that testosterone replacement in hypogonadal men aged 45 to 80 with cardiovascular risk factors did not increase the incidence of major adverse cardiovascular events compared to placebo (NEJM 2023). This data point matters for Michigan telehealth prescribers who previously hesitated to initiate TRT in men with cardiovascular risk profiles.

Pharmacy Options: Retail vs. 503A Compounding in Michigan

Testosterone enanthate is available through two main pharmacy channels in Michigan. Standard retail pharmacies (CVS, Walgreens, Meijer, Rite Aid) stock commercially manufactured testosterone enanthate from brands like Perrigo and Hikma. A 5 mL vial of 200 mg/mL testosterone enanthate typically costs $40 to $90 without insurance at Michigan retail pharmacies, though GoodRx-type coupons can bring the price below $30 in some cases.

The second option is a 503A compounding pharmacy. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, these pharmacies can compound testosterone enanthate based on a valid patient-specific prescription. Michigan's Board of Pharmacy licenses 503A compounding facilities, and these pharmacies may ship compounded testosterone enanthate to patients within the state.

503A compounding pharmacies in Michigan offer several potential advantages:

• Custom concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL)
• Different carrier oils (grapeseed, sesame, or cottonseed) for patients with oil-specific sensitivities
• Bundled supplies including syringes, alcohol swabs, and sharps containers
• Direct-to-patient shipping within Michigan

One practical distinction: commercially manufactured testosterone enanthate from a retail pharmacy has undergone full FDA current Good Manufacturing Practice (cGMP) review. Compounded preparations from 503A pharmacies are not FDA-approved products but are prepared under state pharmacy board oversight and must meet USP 797 sterile compounding standards. Both routes are legal in Michigan for a valid prescription.

Michigan Medicaid and Insurance Coverage

Michigan Medicaid covers testosterone enanthate for the indication of male hypogonadism. Coverage requires prior authorization (PA). The PA process typically requires documentation of:

• Two morning serum total testosterone levels below 300 ng/dL
• Clinical signs and symptoms of hypogonadism (fatigue, decreased libido, erectile dysfunction, loss of muscle mass, depressed mood)
• Ruling out reversible causes of low testosterone (opioid use, exogenous glucocorticoids, uncontrolled diabetes, severe obesity)
• The specific ICD-10 code (E29.1 for testicular hypofunction)

According to CMS data on state Medicaid drug utilization, testosterone products are among the most frequently prior-authorized endocrine drugs across Medicaid programs nationally. In Michigan, PA turnaround from the Medicaid Health Plans typically takes 24 to 72 hours. If the initial request is denied, your prescriber can file a peer-to-peer review.

For commercial insurance, most major Michigan carriers (Blue Cross Blue Shield of Michigan, Priority Health, HAP, McLaren) also cover testosterone enanthate with PA. The Endocrine Society's 2018 guideline is the most commonly referenced document in PA approval criteria. Having your labs, diagnosis, and supporting documentation aligned with these guidelines before submission reduces denial rates significantly.

Out-of-pocket costs vary. Without insurance, the cash price for a month's supply of testosterone enanthate (typically one 5 mL vial lasting 4 to 5 weeks at standard dosing) runs $30 to $90 at Michigan retail pharmacies. Compounded testosterone enanthate from a 503A pharmacy may cost $50 to $150 per month depending on concentration, volume, and whether supplies are bundled.

Dosing, Administration, and Monitoring

The FDA-approved prescribing information for testosterone enanthate specifies intramuscular injection in the gluteal region. Standard dosing for male hypogonadism ranges from 50 to 400 mg every 2 to 4 weeks, though current clinical practice has shifted toward more frequent lower-dose protocols.

Most TRT clinicians in Michigan now prescribe 100 to 200 mg weekly or 50 to 100 mg twice weekly. Splitting the dose reduces peak-trough fluctuations. A study published in the Journal of Clinical Endocrinology & Metabolism found that weekly or twice-weekly injections maintained more stable serum testosterone levels and produced fewer estradiol spikes compared to biweekly or monthly large-dose protocols.

Dr. Shalender Bhasin, a principal investigator of the T-Trials, has stated: "The goal of testosterone replacement is to restore serum testosterone concentrations to the mid-normal range for young men, which is approximately 450 to 600 ng/dL, while monitoring for adverse effects on erythropoiesis and prostate health."

Monitoring after initiation follows the Endocrine Society's recommended schedule:

• 3 months: total testosterone (drawn at trough, just before next injection), CBC (to check hematocrit), estradiol
• 6 months: repeat testosterone, CBC, lipid panel, hepatic function
• 12 months: full panel including PSA (men over 40), DEXA if indicated
• Annually thereafter: testosterone, CBC, lipid panel, PSA

Hematocrit above 54% requires dose reduction or temporary cessation. The T-Trials found that testosterone treatment increased hemoglobin by an average of 1.0 g/dL in anemic men, confirming the erythropoietic effect that demands regular CBC monitoring.

The AUA's 2018 guideline adds: "Clinicians should counsel patients that testosterone therapy may impair fertility, and men who desire fertility should not be started on testosterone replacement without discussing sperm preservation options."

Transferring a Prescription to Michigan

If you hold a valid testosterone enanthate prescription from another state, Michigan pharmacies can generally accept transferred prescriptions for Schedule III controlled substances. The transferring pharmacy must communicate the prescription details directly to the receiving Michigan pharmacy (phone, fax, or electronic transfer per DEA regulations).

Key considerations for interstate transfer:

• The original prescription must have remaining refills
• Michigan's Board of Pharmacy requires that the receiving pharmacist verify the prescription with the transferring pharmacy directly
• Some Michigan pharmacies may request verification of the prescriber's license in the originating state
• If you are switching to a Michigan-based prescriber, they will likely want to review your labs and may order new bloodwork before continuing the prescription

For patients relocating to Michigan, establishing care with a Michigan-licensed TRT provider (either in-person or via telehealth) is the most reliable path to uninterrupted treatment. Most providers can have you up and running within one to two weeks if you bring recent lab results.

Legal Considerations and Controlled Substance Rules

Testosterone enanthate is classified as a Schedule III controlled substance under both federal law and Michigan's Public Health Code. Possessing testosterone enanthate without a valid prescription is a felony in Michigan. Importing testosterone from international pharmacies without a prescription is a federal offense under 21 U.S.C. 952.

Michigan's Automated Prescription System (MAPS) is the state's prescription drug monitoring program. Every Schedule III prescription dispensed in Michigan is reported to MAPS. Your prescriber and pharmacist both have access to your MAPS history, which helps prevent overprescribing and supports continuity of care.

For telehealth prescriptions specifically, the prescriber must be licensed in Michigan (not just their home state) and must hold a DEA registration that covers prescribing to Michigan patients. Legitimate telehealth TRT providers will display their Michigan medical license number.